QHP Capital (QHP), a management company for NovaQuest Private Equity (NQPE), has acquired Lexitas Pharma Services (Lexitas), a full-service ophthalmology contract research organisation (CRO) supporting biopharmaceutical and medical device clinical trials.
Since 2011, Lexitas has provided clinical trial and medical strategy solutions to biopharmaceutical and medical device companies developing ophthalmic products. The Company provides end-to-end support and development expertise in the anterior and posterior segments of ophthalmology.
Additionally, Lexitas appointed Jeanne Hecht as Executive Chairwoman of the Board. Hecht is a seasoned ophthalmology CRO industry executive having previously served as CEO of Ora, an ophthalmic CRO, where she expanded Ora’s international presence, introduced new lines of business, and furthered its goals along numerous strategic paths.
